Time-sensitive and reliable coverage of pharmaceutical industry
developments, clinical trials, treatments and cures worldwide
For 24/7 unlimited access... | |
---|---|
Subscribe now |
or call us on: +43 (0)1 71 72 8 900 (Vienna) |
Templeton Apus GmbH is part of Krixos GmbH, a holding company for what will become a growing collection of companies. Krixos specialises in creating innovative news, intelligence and investment services for customers worldwide.
Templeton Apus is a news, intelligence and research agency that covers all areas of global business, finance and politics. We have developed a specialist news and research technology that is behind the intelligence platforms that we have built.
Our intelligence platforms help businesses worldwide meet exacting and serious information demands whilst also countering disinformation. We provide online access to innovative, critical, up to the minute and reliable global news, intelligence and analysis, and have built our platforms to be future proof – as demands grow, so will our services.
The first service that we developed was the Templeton Apus intelligence platform. It provides an essential news and information advantage to customers in markets across 47 sectors and industries. These are as wide ranging as Energy to Mining, Healthcare to Media & ICT, Agribusiness to Banking, and Aerospace to Chemicals. It also provides up to the minute reporting on global hot spots such as Ukraine, Israel, Niger, Armenia and Taiwan.
Since then, we have developed our TA TA RawMaterials intelligence platform, with support from EIT RawMaterials and co-funding from the European Union. TA RawMaterials covers the Mining and Metals sector. It also reports all news and intelligence covering 30 associated sectors, including Renewable Energy, Electric Vehicles, Battery Storage, Climate and the Environment. We plan to spin out TA RawMaterials as a stand alone Krixos company.
We have also developed our Cancer Stat intelligence platform. It provides the healthcare and pharmaceutical sector with indepth 24/7 pharmaceutical news, and extensive updates on all types of Cancer treatments worldwide.
Our customers are corporates, multinationals, banks, VCs, governmental departments, embassies and consultancies worldwide. We provide them with unlimited access to the information they want, when they need it. Our customers are also able to request the addition of extra service features and content.
From our head office in Vienna, and our office in London, our time-sensitive news and intelligence coverage across all sectors includes Europe, Russia, North & South America, Asia-Pacific, Africa and the Middle East.
Our services have been optimised for speed, quality and content. They will continue to revolutionise the industry by providing superior news and intelligence that is reliable, independent and interactive.
Cancer Stat is the global benchmark for reliable and time-sensitive cancer news, research and analysis.
Its user-friendly online platform and its extensive email services cover everything from upcoming clinical trials, to the real-time approval of new cancer drugs and treatments worldwide.
Our service provides corporates, healthcare and pharmaceutical professionals, consultants, and cancer patients with personalised and indepth 24/7 treatment news, and extensive updates on all types of cancer.
Corporates are able to follow news and analysis on the daily activities of 6,952 pharmaceutical and healthcare companies worldwide. Patients are able to follow news and research on the treatments that they are receiving, and on the alternatives, from reliable and reputable sources.
Whether you are a professional or a patient, you have your own login account enabling you to access the whole service, and to view and to receive exactly what you want when you need it.
To do our best to help save lives worldwide.